Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Waters Corp. closed 32.12% below its 52-week high of $423.56, which the company achieved on January 30th.

This was the stock's second consecutive day of losses.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Waters will pay Becton shareholders $4 billion in cash—raised through debt—and the remainder in stock. Waters shareholders ...

Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Waters Corporation (NYSE: WAT) and Becton, ...